The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Herbal, Ayurvedic & Traditional Wellness FMCG Market Forecasts to 2032 – Global Analysis By Product (Personal Care, Health & Wellness Supplements, Functional Foods & Beverages, Traditional Medicines, and Aromatherapy & Essential Oils), Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Herbal, Ayurvedic & Traditional Wellness FMCG Market is accounted for $1018.67 billion in 2025 and is expected to reach $2931.51 billion by 2032 growing at a C...
January 2026
200 pages
Aminoglycosides Market - 2022
US$ 2,999.00
The Aminoglycosides Market was valued at USD 1,636.4 million in 2022 and is anticipated to reach by , at a CAGR of 0.038 from 2026 to 2032. The report delivers in-depth insights into key market dynami...
December 2025
200 pages
Bladder Prolapse (Cystocele) Market 2026
US$ 2,999.00
The Bladder Prolapse (Cystocele) Market was valued at in and is anticipated to reach by , at a CAGR of 0.083 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
December 2025
210 pages
C3 Glomerulopathy Treatment Market 2026
US$ 2,999.00
The C3 Glomerulopathy Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
December 2025
220 pages
Cold Agglutinin Disease Treatment Market 2026
US$ 2,999.00
The Cold Agglutinin Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
December 2025
218 pages
Cryoglobulinemia Treatment Market 2026
US$ 2,999.00
The Cryoglobulinemia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
December 2025
207 pages
Cystinosis Treatment Market 2026
US$ 2,999.00
The Cystinosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
December 2025
207 pages
Cystinuria Treatment Market - 2022-2030
US$ 2,999.00
The Cystinuria Treatment Market was valued at USD 110.7 million in 2022 and is anticipated to reach USD 153.8 million by 2030, at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insigh...
December 2025
200 pages
End Stage Renal Disease Market 2026
US$ 2,999.00
The End Stage Renal Disease Market was valued at in and is anticipated to reach by , at a CAGR of 0.127 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
December 2025
219 pages
Erosive Hand Osteoarthritis Market 2026
US$ 2,999.00
The Erosive Hand Osteoarthritis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
December 2025
220 pages
Europe Gout Therapeutics Market 2026
US$ 2,999.00
The Europe Gout Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
December 2025
217 pages
Follicle Stimulating Hormone Market - 2022
US$ 2,999.00
The Follicle Stimulating Hormone Market was valued at US$ 1.9 billion in 2022 and is anticipated to reach by , at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insights into key mark...
December 2025
200 pages
Fucosidosis Treatment Market 2026
US$ 2,999.00
The Fucosidosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
December 2025
219 pages
Hashimoto's Thyroiditis Drug Market 2026
US$ 2,999.00
The Hashimoto's Thyroiditis Drug Market was valued at in and is anticipated to reach by , at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
December 2025
243 pages
Hemangioma Treatment Market - 2022-2030
US$ 2,999.00
The Hemangioma Treatment Market was valued at USD 284.6 million in 2022 and is anticipated to reach USD 381.0 million by 2030, at a CAGR of 0.038 from 2026 to 2032. The report delivers in-depth insigh...
December 2025
210 pages
Hemophagocytic Lymphohistiocytosis Treatment Market 2026
US$ 2,999.00
The Hemophagocytic Lymphohistiocytosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyna...
December 2025
243 pages
HIV-associated Lipodystrophy Market - 2022-2030
US$ 2,999.00
The HIV-associated Lipodystrophy Market was valued at US$ 174.90 million in 2022 and is anticipated to reach US$ 228.11 million by 2030, at a CAGR of 0.034 from 2026 to 2032. The report delivers in-de...
December 2025
210 pages
Homocystinuria Market 2026
US$ 2,999.00
The Homocystinuria Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
December 2025
243 pages
Hyperuricemia Market - 2022-2030
US$ 2,999.00
The Hyperuricemia Market was valued at US$ 1.6 billion in 2022 and is anticipated to reach US$ 3.4 billion by 2030, at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth insights into key...
December 2025
217 pages
Idiopathic Short Stature Treatment Market 2026
US$ 2,999.00
The Idiopathic Short Stature Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
December 2025
210 pages
Isovaleric Acidemia Market 2026
US$ 2,999.00
The Isovaleric Acidemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
December 2025
217 pages
Limb Girdle Muscular Dystrophy Treatment Market 2026
US$ 2,999.00
The Limb Girdle Muscular Dystrophy Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics...
December 2025
243 pages
Lyophilized Antivenins Market 2026
US$ 2,999.00
The Lyophilized Antivenins Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
December 2025
218 pages
Maple Syrup Urine Disease Treatment Market 2026
US$ 2,999.00
The Maple Syrup Urine Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
December 2025
218 pages
Necrotizing Enterocolitis Drugs Market 2026
US$ 2,999.00
The Necrotizing Enterocolitis Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
December 2025
243 pages
Neonatal Biotinidase Treatment Market 2026
US$ 2,999.00
The Neonatal Biotinidase Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
December 2025
243 pages
Neurogenic Bladder Infections Market 2026
US$ 2,999.00
The Neurogenic Bladder Infections Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
December 2025
218 pages
Paget's Disease Market 2026
US$ 2,999.00
The Paget's Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
December 2025
219 pages
Phosphoglucomutase (PGM 1) Deficiency Market 2026
US$ 2,999.00
The Phosphoglucomutase (PGM 1) Deficiency Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
December 2025
223 pages
Pituitary Stalk Interruption Syndrome (PSIS) Market 2026
US$ 2,999.00
The Pituitary Stalk Interruption Syndrome (PSIS) Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyna...
December 2025
200 pages
Pneumothorax Treatment Market 2026
US$ 2,999.00
The Pneumothorax Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
December 2025
243 pages
Polymyalgia Rheumatica Treatment Market 2026
US$ 2,999.00
The Polymyalgia Rheumatica Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
December 2025
200 pages
Post-operative Pain Therapeutics Market 2026
US$ 2,999.00
The Post-operative Pain Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
December 2025
217 pages
Propionic Acidemia Drugs Market 2026
US$ 2,999.00
The Propionic Acidemia Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
December 2025
220 pages
Rickets Treatment Market 2026
US$ 2,999.00
The Rickets Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.084 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
December 2025
210 pages
Rosai-Dorfman Disease Market - 2022-2030
US$ 2,999.00
The Rosai-Dorfman Disease Market was valued at US$ 405.0 million in 2022 and is anticipated to reach US$ 667.5 million by 2030, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insig...
December 2025
243 pages
Sarcopenia Treatment Market - 2018
US$ 2,999.00
The Sarcopenia Treatment Market was valued at 52 million in 2018 and is anticipated to reach by , at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
December 2025
218 pages
Secondary Hyperparathyroidism Treatment Market - 2022-2030
US$ 2,999.00
The Secondary Hyperparathyroidism Treatment Market was valued at US$ 4.3 billion in 2022 and is anticipated to reach US$ 8.5 billion by 2030, at a CAGR of 0.092 from 2026 to 2032. The report delivers...
December 2025
210 pages
Spina Bifida Treatment Market 2026
US$ 2,999.00
The Spina Bifida Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.078 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
December 2025
220 pages
Systemic Juvenile Idiopathic Arthritis Market - 2022-2030
US$ 2,999.00
The Systemic Juvenile Idiopathic Arthritis Market was valued at US$ 0.87 billion in 2022 and is anticipated to reach US$ 1.19 billion by 2030, at a CAGR of 0.041 from 2026 to 2032. The report delivers...
December 2025
243 pages
Tay-Sachs Disease Treatment Market 2026
US$ 2,999.00
The Tay-Sachs Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
December 2025
243 pages
Hyaluronic Acid Raw Material Market Size, Share & Trends Analysis Report By Application (Pharmaceutical & Medical, Cosmetic & Aesthetic, Nutraceutical & Food Supplement), By Source (Non-animal, Animal), By Grade (Cosmetic Grade, Food Grade), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... hyaluronic acid raw material market is expected to reach a value of USD 7.25 billion by 2024, according to a new report by Grand View Research, Inc. The increasing use of hyaluronic acid ... of osteoarthritis The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC ...
December 2025
150 pages
